Diet High in Good Fats Just as Beneficial to Persons With Diabetes
CINCINNATIA new study by researchers at the University of Cincinnati (UC) finds that a low-carbohydrate, high-monounsaturated fat diet was just as beneficial for persons with type 2 diabetes as the traditional low-fat, high-carbohydrate diet.
The most important aspect of this research is that there are alternatives to the conventional low-fat, high-carb diet, says the studys principal investigator, Bonnie Brehm, PhD.
Brehm, a registered dietitian and professor at UCs
Several small studies had previously suggested that Mediterranean diets, with a large proportion of their fat content made up of monounsaturated fats such as olive oil, had beneficial effects on blood glucose and lipid levels in patients with diabetes. However, these results had been lost in the rush by dietitians and clinicians to reduce patients fat intake, and Mediterranean diets had not been tested in larger, longer-term studies of persons with diabetes.
The thinking has always been that high-fat diets were not healthy for anybody, says Brehm, but this shows that you can recommend a higher-fat diet, as long as it is healthy fat.
According to the study, reported first in the Oct. 28 e-publication of Diabetes Care, both diets were found to be equally beneficial: Both groups had similar weight loss over one year (approximately 4 kilograms, or 9 pounds) and had comparable improvement in body fat, waist circumference, diastolic blood pressure, HDL cholesterol, A1C and fasting glucose and insulin.
While a 4-kilogram weight loss is much less than what most patients want for cosmetic reasons, this is a clinically significant reduction, DAlessio says. Weight loss of this magnitude can improve blood pressure as well as lipid and glucose values, and also can reduce the number of medications people need to take.
The American Diabetes Association (ADA), which funded the UC study, reports that 23.6 million children and adults in the
Type 2 diabetes is a particularly important problem in the
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.